Page last updated: 2024-11-07

4-azido-3-iodobenzylcarazolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-azido-3-iodobenzylcarazolol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128544
CHEMBL ID423829
MeSH IDM0109688

Synonyms (8)

Synonym
paibc
83538-85-6
CHEMBL423829
2-propanol, 1-((2-(4-azido-3-iodophenyl)-1,1-dimethylethyl)amino)-3-(9h-carbazol-4-yloxy)-
4-azido-3-iodobenzylcarazolol
para-azido-m-iodobenzylcarazolol
DTXSID801003536
1-{[1-(4-azido-3-iodophenyl)-2-methylpropan-2-yl]amino}-3-[(9h-carbazol-4-yl)oxy]propan-2-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID41148Dissociation constant against beta adrenergic receptor of frog erythrocyte membranes1983Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
Synthesis of iodine-125 labeled (+/-)-15-(4-azidobenzyl)carazolol: a potent beta-adrenergic photoaffinity probe.
AID41149Dissociation constant against beta adrenergic receptor of turkey erythrocyte membranes1983Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
Synthesis of iodine-125 labeled (+/-)-15-(4-azidobenzyl)carazolol: a potent beta-adrenergic photoaffinity probe.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]